Policlínica Nuestra Señora del Rosario is our new clinical routine customer in Spain
Wed Feb 03 2021
Policlínica Nuestra Señora del Rosario is the newest addition to our list of already established customers in Spain.
The customer is a private hospital located in Ibiza. The hospital has around 70 beds offering both acute care treatment and out-patient treatments for locals and tourists. The uptake population is approximately 50,000 people and the hospital also has three smaller associated clinics.
The hospital will immediately implement suPARnostic® TurbiLatex on its Roche cobas 501 system. This decision is based on references from other hospital users in Spain and abroad without previous on-site experience.
Our product will be implemented to improve the hospital’s triage of COVID-19 patients as well as other patients in acute care.
Jakob Knudsen, Chief Executive Officer of ViroGates, said:
”We are happy to add another clinical customer to our list of already established customers in Spain. We are particularly encouraged to see that this customer has decided to implement suPARnostic® based on data from peers in Spain and abroad without previous on-site experience. This shows that clinical evidence, local reference hospitals and our targeted marketing work in combination to convince customers who have not been acquainted with our products previously.”
